Efficacy and safety of artificial tears containing extract with dinucleotides for dry eye.

Clinical Relevance: This clinical trial was conducted as part of the marketing procedures for a medical device comprising artificial tears containing extract with dinucleotides. These molecules previously demonstrated secretagogue properties by enhancing the production of aqueous, mucinous, and lipidic components of the tears.

Background: After confirming the efficacy of artificial tears containing extract in an animal model, this study proceeded to evaluate their efficacy and safety on dry eye participants.